-+ 0.00%
-+ 0.00%
-+ 0.00%

*AbCellera Biologics Plans To Use Net Proceeds From Offering to Fund Continued Research, Development and Clinical Advancement of Its Internal Pipeline >ABCL

Dow Jones·08/13/2026 04:11:00

Please log in to view news